Oxford Gene Technology Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
135
- Latest Deal Type
-
M&A
Oxford Gene Technology General Information
Description
Provider of genetics research and biomarker services based in Begbroke, United Kingdom. The company's genetics research and biomarker services offer genomic technologies that help in solid tumor panel and RNA sequencing and also assist in gene expression analysis, enabling clinical and academic research industries to accurately identify causative variation underlying genetic diseases.
Contact Information
Website
www.ogt.com(Operating Subsidiary)
Corporate Office
- Begbroke Science Park
- Begbroke Hill, Woodstock Road, Oxfordshire
- Begbroke OX5 1PF
- England, United Kingdom
Corporate Office
- Begbroke Science Park
- Begbroke Hill, Woodstock Road, Oxfordshire
- Begbroke OX5 1PF
- England, United Kingdom
Oxford Gene Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 02-Jun-2017 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2012 | 00.000 | Completed | Generating Revenue | ||
| 2. Grant | 21-Jun-2011 | $1.89M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 01-Jan-1995 | Completed | Startup |
Oxford Gene Technology Comparisons
Industry
Financing
Details
000000
00000
Oxford Gene Technology Competitors (23)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Unchained Labs | Private Equity-Backed | Pleasanton, CA | 000 | 00000 | 000000000 - | |
| Yikon Genomics | Private Equity-Backed | Shanghai, China | 0000 | 00000 | 00000000000 | 00000 |
| Luminex | Corporate Backed or Acquired | Austin, TX | 0000 | 000.00 | 000000&0 | 000.00 |
| Agena Bioscience | Formerly PE-Backed | San Diego, CA | 000 | 0000 | 000000&0 | 0000 |
| Promega | Formerly PE-Backed | Madison, WI | 0000 | 000000000000 |
Oxford Gene Technology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Oxford Gene Technology Patents
Oxford Gene Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2850206-A1 | Methods of quantifying of nucleic acids captured on a solid support. | Inactive | 17-May-2012 | 0000000000 | |
| GB-201208726-D0 | Methods and materials | Inactive | 17-May-2012 | 0000000000 | |
| US-20150141277-A1 | Methods of quantifying of nucleic acids captured on a solid support | Inactive | 17-May-2012 | 0000000000 | 0 |
| GB-201000315-D0 | Combined cgh & allele specific hybridisation method | Inactive | 08-Jan-2010 | ||
| US-20170154152-A1 | Combined cgh & allele specific hybridisation method | Active | 08-Jan-2010 | 0 |
Oxford Gene Technology Executive Team (12)
| Name | Title | Board Seat |
|---|---|---|
| Adrian Smith | Chief Executive Officer | |
| Greg Williams | Chief Financial Officer | |
| Gareth Thomson | Executive Vice President, Commercial Operations | |
| Emma Shipstone Ph.D | Executive Vice President for Strategic Business Development | |
| Edwin Southern | Founder |
Oxford Gene Technology Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Owen Ph.D | Self | Board Member | 000 0000 |
| David Oxlade | Oxford Gene Technology | Chairman | 000 0000 |
Oxford Gene Technology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Oxford Gene Technology Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Union | Government | 000 0000 | 000000 0 | |
| Innovate UK | Accelerator/Incubator | 000 0000 | 000000 0 | |
| Oxford Spin-out Equity Management | Venture Capital | Minority | 000 0000 | 000000 0 |
| Oxford University Innovation | University | Minority | 000 0000 | 000000 0 |
| University of Oxford Endowment | Limited Partner | Majority | 000 0000 | 000000 0 |
Oxford Gene Technology Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cytocell Technologies | 14-Feb-2014 | 0000000000 | Other Healthcare Services | ||
| Sense Proteomic | 17-Mar-2009 | Merger/Acquisition | Drug Discovery |
Oxford Gene Technology FAQs
-
When was Oxford Gene Technology founded?
Oxford Gene Technology was founded in 1995.
-
Who is the founder of Oxford Gene Technology?
Edwin Southern is the founder of Oxford Gene Technology.
-
Who is the CEO of Oxford Gene Technology?
Adrian Smith is the CEO of Oxford Gene Technology.
-
Where is Oxford Gene Technology headquartered?
Oxford Gene Technology is headquartered in Begbroke, United Kingdom.
-
What is the size of Oxford Gene Technology?
Oxford Gene Technology has 135 total employees.
-
What industry is Oxford Gene Technology in?
Oxford Gene Technology’s primary industry is Discovery Tools (Healthcare).
-
Is Oxford Gene Technology a private or public company?
Oxford Gene Technology is a Private company.
-
What is Oxford Gene Technology’s current revenue?
The current revenue for Oxford Gene Technology is 000000.
-
Who are Oxford Gene Technology’s investors?
European Union, Innovate UK, Oxford Spin-out Equity Management, Oxford University Innovation, and University of Oxford Endowment have invested in Oxford Gene Technology.
-
Who are Oxford Gene Technology’s competitors?
Unchained Labs, Yikon Genomics, Luminex, Agena Bioscience, and Promega are some of the 23 competitors of Oxford Gene Technology.
-
When was Oxford Gene Technology acquired?
Oxford Gene Technology was acquired on 02-Jun-2017.
-
Who acquired Oxford Gene Technology?
Oxford Gene Technology was acquired by Sysmex (Diagnostic Equipment).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
